Literature DB >> 12454863

National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C 2002 (June 10-12, 2002).

.   

Abstract

Mesh:

Year:  2002        PMID: 12454863     DOI: 10.1053/gast.2002.1232082

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  57 in total

Review 1.  Guidelines for stopping therapy in chronic hepatitis C.

Authors:  Mark W Russo; Michael W Fried
Journal:  Curr Gastroenterol Rep       Date:  2004-02

Review 2.  Current therapy for hepatitis C.

Authors:  Mireen Friedrich-Rust; Stefan Zeuzem; Christoph Sarrazin
Journal:  Int J Colorectal Dis       Date:  2005-09-21       Impact factor: 2.571

Review 3.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

Review 4.  Hepatitis C infection with normal liver chemistry tests.

Authors:  Michael W Fried
Journal:  Clin Gastroenterol Hepatol       Date:  2008-04-14       Impact factor: 11.382

5.  Marked flare in hepatic aminotransferases during treatment with pegylated interferon for chronic hepatitis C, genotype 2: a case report.

Authors:  Poonam Mishra; Amanda DeVoss; Rish Pai; John Hart; Donald M Jensen
Journal:  Dig Dis Sci       Date:  2008-09-04       Impact factor: 3.199

6.  Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C.

Authors:  John R Petersen; Heather L Stevenson; Krishna S Kasturi; Ashutosh Naniwadekar; Julie Parkes; Richard Cross; William M Rosenberg; Shu-Yuan Xiao; Ned Snyder
Journal:  J Clin Gastroenterol       Date:  2014-04       Impact factor: 3.062

7.  Prediagnostic serum organochlorine insecticide concentrations and primary liver cancer: A case-control study nested within two prospective cohorts.

Authors:  Lawrence S Engel; Emily C Zabor; Jaya Satagopan; Anders Widell; Nathaniel Rothman; Thomas R O'Brien; Mingdong Zhang; Stephen K Van Den Eeden; Tom K Grimsrud
Journal:  Int J Cancer       Date:  2019-02-14       Impact factor: 7.396

Review 8.  Murine models of hepatitis C: what can we look forward to?

Authors:  Markus von Schaewen; Alexander Ploss
Journal:  Antiviral Res       Date:  2014-01-24       Impact factor: 5.970

9.  The evolution of the major hepatitis C genotypes correlates with clinical response to interferon therapy.

Authors:  Phillip S Pang; Paul J Planet; Jeffrey S Glenn
Journal:  PLoS One       Date:  2009-08-11       Impact factor: 3.240

10.  Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response.

Authors:  Eric Chak; Sammy Saab
Journal:  Curr Hepat Rep       Date:  2010-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.